References
- Siegel RL , MillerKD , JemalA. Cancer statistics, 2018. Cancer J. Clin.68(1), 7–30 (2018).
- Ettinger DS , WoodDE , AkerleyWet al. non-small-cell lung cancer, version 6.2015. J. Natl Compr. Canc. Netw.13(5), 515–524 (2015).
- Goldstraw P , ChanskyK , CrowleyJet al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J. Thorac. Oncol.11(1), 39–51 (2016).
- Shah R , SabanathanS , RichardsonJ , MearnsAJ , GouldenC. Results of surgical treatment of stage I and II lung cancer. J. Cardiovasc. Surg.37(2), 169–172 (1996).
- Jaenisch R , BirdA. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet.33, 245–254 (2003).
- Vaissiere T , SawanC , HercegZ. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res.659(1-2), 40–48 (2008).
- Suvà ML , RiggiN , BernsteinBE. Epigenetic reprogramming in cancer. Science339(6127), 1567–1570 (2013).
- Tomasetti M , AmatiM , NeuzilJ , SantarelliL. Circulating epigenetic biomarkers in lung malignancies: from early diagnosis to therapy. Lung cancer107, 65–72 (2017).
- Wang YC , LuYP , TsengRCet al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J. Clin. Invest.111(6), 887–895 (2003).
- Licchesi JD , WestraWH , HookerCM , HermanJG. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin. Cancer Res.14(9), 2570–2578 (2008).
- Dammann R , StrunnikovaM , SchagdarsurenginUet al. CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur. J. Cancer41(8), 1223–1236 (2005).
- Belinsky SA , GrimesMJ , CasasEet al. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br. J. Cancer96(8), 1278–1283 (2007).
- Lokk K , VooderT , KoldeRet al. Methylation markers of early-stage non-small-cell lung cancer. PLoS ONE7(6), e39813983 (2012).
- Tian W , LiYS , ZhangJH , LiJJ , GaoJH. Comprehensive analysis of DNA methylation and gene expression datasets identified MMP9 and TWIST1 as important pathogenic genes of lung adenocarcinoma. DNA Cell Biol.37(4), 336–346 (2018).
- Kim Y , KimDH. CpG island hypermethylation as a biomarker for the early detection of lung cancer. Methods Mol. Biol.1238, 141–171 (2015).
- Selamat SA , ChungBS , GirardLet al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res.22(7), 1197–1211 (2012).
- Keeley B , StarkA , PisanicTR2ndet al. Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin. Chim. Acta425, 169–175 (2013).
- Dai W , TeodoridisJM , ZellerCet al. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival. Clin. Cancer Res.17(12), 4052–4062 (2011).
- How Kit A , NielsenHM , TostJ. DNA methylation based biomarkers: practical considerations and applications. Biochimie94(11), 2314–2337 (2012).
- Hao X , LuoH , KrawczykMet al. DNA methylation markers for diagnosis and prognosis of common cancers. Proc. Natl Acad. Sci. USA114(28), 7414–7419 (2017).
- Guo W , ZhuL , YuM , ZhuR , ChenQ , WangQ. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma. Clin. Epigenetics10(1), 142 (2018).
- Dong Y , HuayingS , DanyingWet al. Significance of methylation of FBP1 gene in non-small-cell lung cancer. Biomed Res. Int.2018, 3726091 (2018).
- Gao C , ZhuangJ , ZhouCet al. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: a study based on The Cancer Genome Atlas. J. Cell. Physiol. doi:10.1002/jcp.27389 (2018) ( Epub ahead of print).
- Guo Y , ZhangR , ShenSet al. DNA methylation of LRRC3B: a biomarker for survival of early-stage non-small-cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev.27(12), 1527–1535 (2018).
- Zhao M , KimP , MitraR , ZhaoJ , ZhaoZ. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res.44(D1), D1023–D1031 (2016).
- Zhao M , SunJ , ZhaoZ. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res.41(D1), D970–D976 (2013).
- Sherr CJ . Principles of tumor suppression. Cell116(2), 235–246 (2004).
- Ho C-M , HuangC-J , HuangC-Y , WuY-Y , ChangS-F , ChengW-F. Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma. Mol. Cancer11, 53–53 (2012).
- Stordal B , DaveyR. A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. Curr. Cancer Drug Targets9(3), 354–365 (2009).
- Visser-Grieve S , HaoY , YangX. Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway. Oncogene31(9), 1189–1195 (2012).
- Croes L , BeyensM , FransenEet al. Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer. Clin. Epigenetics10, 51 (2018).
- Shen F , ZhengH , ZhouL , LiW , LiuJ , XuX. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer. J. Cell. Physiol. doi:10.1002/jcp.27453 (2018) ( Epub ahead of print).
- Ko JM , ChanPL , YauWLet al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol. Cancer Res.6(4), 592–603 (2008).
- Khamas A , IshikawaT , MogushiKet al. Genome-wide screening for methylation-silenced genes in colorectal cancer. Int. J. Oncol.41(2), 490–496 (2012).
- He W , JuD , JieZ , ZhangA , XingX , YangQ. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma. Cancer Med.7(11), 5716–5726 (2018).
- Dmitriev AA , KashubaVI , HaraldsonKet al. Genetic and epigenetic analysis of non-small-cell lung cancer with NotI-microarrays. Epigenetics7(5), 502–513 (2012).
- Leong KG , KarsanA. Recent insights into the role of Notch signaling in tumorigenesis. Blood107(6), 2223–2233 (2006).
- Croce JC , McclayDR. Evolution of the Wnt pathways. Methods Mol. Biol.469, 3–18 (2009).
- Krishnamurthy N , KurzrockR. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat. Rev.62, 50–60 (2018).